These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32687175)

  • 1. Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy.
    Nikhanj A; Miskew Nichols B; Wang K; Siddiqi ZA; Oudit GY
    Eur Heart J Qual Care Clin Outcomes; 2021 Oct; 7(6):564-573. PubMed ID: 32687175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectory of left ventricular ejection fraction in response to therapies in patients with muscular dystrophy.
    Nikhanj A; Kashyap N; Wang K; Phan CL; Siddiqi ZA; Becher H; Oudit GY
    Echocardiography; 2022 Oct; 39(10):1328-1337. PubMed ID: 36198087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation.
    Moon YJ; Kwon HM; Jung KW; Kim KS; Shin WJ; Jun IG; Song JG; Hwang GS
    Korean J Anesthesiol; 2021 Jun; 74(3):242-253. PubMed ID: 32846082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic stratification of patients with chronic systolic heart failure using biomarkers and Doppler echocardiography.
    Ghio S; Alessandrino G; Albertini R; Klersy C; Girardi B; Maggi G; Pazzano AS; Raineri C; Scelsi L; Visconti LO
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):470-5. PubMed ID: 24983266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up.
    Rajagopalan S; Croal BL; Reeve J; Bachoo P; Brittenden J
    Eur J Vasc Endovasc Surg; 2011 May; 41(5):657-62. PubMed ID: 21330158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery.
    Yang HS; Hur M; Yi A; Kim H; Kim J
    Ann Lab Med; 2018 May; 38(3):204-211. PubMed ID: 29401554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity Troponin I Predicts Major Cardiovascular Events after Non-Cardiac Surgery: A Vascular Events in Non-Cardiac Surgery Patients Cohort Evaluation (VISION) Substudy.
    Borges FK; Duceppe E; Heels-Ansdell D; Patel A; Sessler DI; Tandon V; Chan M; Pearse R; Srinathan S; Garg AX; Sapsford RJ; Ofori SN; Marcucci M; Kavsak PA; Pettit S; Spence J; Belley-Cote E; McGillion M; Whitlock R; Lamy A; Conen D; Thomas S; Mueller C; Jaffe AS; Devereaux PJ
    Clin Chem; 2023 Apr; 69(5):492-499. PubMed ID: 36762424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
    Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of perioperative cardiac events through preoperative NT-pro-BNP and cTnI after emergent non-cardiac surgery in elderly patients.
    Ma J; Xin Q; Wang X; Gao M; Wang Y; Liu J
    PLoS One; 2015; 10(3):e0121306. PubMed ID: 25799524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-specific cut-off values for soluble suppression of tumorigenicity 2 (ST2) biomarker increase its cardiovascular prognostic value in the community.
    Harmon DM; AbouEzzeddine OF; McKie PM; Scott CG; Saenger AK; Jaffe AS
    Biomarkers; 2021 Nov; 26(7):639-646. PubMed ID: 34269635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Intervention Improves Heart Disease and Clinical Outcomes in Patients With Muscular Dystrophy in a Multidisciplinary Care Setting.
    Nikhanj A; Yogasundaram H; Miskew Nichols B; Richman-Eisenstat J; Phan C; Bakal JA; Siddiqi ZA; Oudit GY
    J Am Heart Assoc; 2020 Jan; 9(2):e014004. PubMed ID: 31931688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of peri-procedural B-type natriuretic peptide levels in predicting cardiac events after elective percutaneous coronary intervention.
    Yildirir A; Acikel S; Ertan C; Aydinalp A; Ozin B; Muderrisoglu H
    Acta Cardiol; 2008 Feb; 63(1):47-52. PubMed ID: 18372580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of early postoperative major cardiac events after elective orthopedic surgery: the role of B-type natriuretic peptide, the revised cardiac risk index, and ASA class.
    Vetrugno L; Langiano N; Gisonni R; Rizzardo A; Venchiarutti PE; Divella M; Pompei L; Causero A; Rocca GD
    BMC Anesthesiol; 2014 Mar; 14():20. PubMed ID: 24655733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Point-of-Care and Serial B-type Natriuretic Peptide Levels in Patients With Hypertrophic Cardiomyopathy.
    Siriwardena M; Bagai A; Delgado D; Ross HJ; Rozenblyum E; Rakowski H; Woo A; Thavendiranathan P
    Am J Cardiol; 2018 Oct; 122(8):1421-1428. PubMed ID: 30111486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study.
    Matsumura T; Hashimoto H; Sekimizu M; Saito AM; Motoyoshi Y; Nakamura A; Kuru S; Fukudome T; Segawa K; Takahashi T; Tamura T; Komori T; Watanabe C; Asakura M; Kimura K; Iwata Y
    Orphanet J Rare Dis; 2022 May; 17(1):201. PubMed ID: 35578298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse outcomes in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Baba Y; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Circ J; 2011; 75(4):919-26. PubMed ID: 21304210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy.
    Everett BM; Zeller T; Glynn RJ; Ridker PM; Blankenberg S
    Circulation; 2015 May; 131(21):1851-60. PubMed ID: 25825410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide.
    Valaperta R; De Siena C; Cardani R; Lombardia F; Cenko E; Rampoldi B; Fossati B; Brigonzi E; Rigolini R; Gaia P; Meola G; Costa E; Bugiardini R
    Atherosclerosis; 2017 Dec; 267():110-115. PubMed ID: 29121498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.